Unibest

Pharmaceutical intermediates

Paxlovid Intermediates

3 pharmaceutical intermediates for Paxlovid. Indication: SARS-CoV-2 infection.

提交项目All intermediates

About Paxlovid

Originator
Pfizer Inc
Indication
SARS-CoV-2 infection
Approved Date
02/11/2022

Available intermediates

3 intermediates currently listed for Paxlovid. Request specifications, documentation or a quotation for any item below.

Paxlovid intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
BOC-3,4-DEHYDRO-PRO-OH51154-06-4//
Methyl N-Boc-L-proline-3-ene74844-93-2//
Boceprevir InterMediates565456-77-1//

Other programs under P

PacritinibPalbociclibParecoxib sodiumParicalcitolPazopanib HydrochloridePeficitinib HydrobromidePemafibratePeramivir

Building toward Paxlovid?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →